Depressive Personality Disorder
Depressive personality disorder (also known as melancholic personality disorder) is a psychiatric diagnosis that denotes a personality disorder with depressive features. Originally included in the American Psychiatric Association’s DSM-II, depressive personality disorder was removed from the DSM-III and DSM-III-R.
Cluster Number:
Wiki Number: W059
Diagnosis: Depressive Personality Disorder
US Patients:
World Patients:
Sex Ratio:
Age Onset:
Brain Area: None listed.
Symptoms: 2 years: mood is usually joyless, low self-esteem, self-derogatory, pessimistic, guilty, remorseful, judgmental to others
Progression: pervasive negative pattern before, during, after depressive episodes; difficulty developing and maintaining relationships
Causes: None listed.
Medications: None listed.
Therapies: None listed.
Youtube Video: How To Overcome Depressive Personality Disorder
Amazon or Library Book: Depressive Personality Disorder
Click the book to link or order from Amazon.
Support Group: dbsalliance.org; It has a search function for area groups. (Depression and Bipolar Suppor Alliance)
Contact your local Social Security office for possible Disability Benefits through their Disability Determination Services,
Section 12.04.
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Case report: Intensive online trauma treatment combining prolonged exposure and EMDR 2.0 in a patient with severe and chronic PTSDby Suzy J M A Matthijssen on May 7, 2024
CONCLUSION: In conclusion, the case-report demonstrates that intensive trauma treatment online was successful in this specific case, thereby being a 'proof of concept' that intensive trauma treatment online is feasible. It might be promising for patients with severe and chronic PTSD and comorbid psychiatric disorders. However, further research must show if the results of this specific case can be translated to other patients with severe and chronic PTSD and comorbid psychiatric disorders.
- Patterns of cognitive-emotional change after cognitive-behavioural treatment in emotional disorders: A 12-month longitudinal cluster analysisby Sara Barrio-Martínez on May 7, 2024
CONCLUSIONS: These results underscore the value of adding TD-CBT to reduce maladaptive cognitive-emotional regulation strategies. These findings highlight the importance of the processes of change in therapy and demonstrate the relevance of the patient's cognitive-emotional profile in improving treatment outcomes.
- Very Low-Dose Sublingual Ketamine for Borderline Personality Disorder and Treatment-Resistant Depressionby Mitchell Liester on May 6, 2024
Borderline personality disorder (BPD) and treatment-resistant depression (TRD) are common mental disorders that are challenging to treat. Ketamine is an N-methyl-D-aspartate receptor antagonist that has shown promise as a rapid-acting antidepressant when administered intravenously. BPD symptoms have also been demonstrated to improve with repeated intravenous administration of ketamine, and a single case report described improvement in BPD following the intranasal administration of esketamine. We...
- Are visual analogue scales valid instruments to measure psychological pain in psychiatric patients?by Adrián Alacreu-Crespo on May 5, 2024
CONCLUSION: The PPP-VAS showed good psychometric properties in evaluating psychological pain. The characteristics of the PPP-VAS makes this scale a great option for its use in clinical practice to detect patients at risk of suicide.